An Update on Further Progression of NAFLD, NASH with Prospective Therapies Like L-Carnitine (LC), Nicotinamide Ribose (NR) Combination, as well as Apical Sodium Dependent Bile Acids Transporter (ASBT) or Volixibat and Silybin as Alternatives

التفاصيل البيبلوغرافية
العنوان: An Update on Further Progression of NAFLD, NASH with Prospective Therapies Like L-Carnitine (LC), Nicotinamide Ribose (NR) Combination, as well as Apical Sodium Dependent Bile Acids Transporter (ASBT) or Volixibat and Silybin as Alternatives
المؤلفون: Kulvinder Kochar Kaur, Gautam Allahbadia, Mandeep Singh
بيانات النشر: Zenodo, 2020.
سنة النشر: 2020
مصطلحات موضوعية: NAFLD, NASH, L-Carnitine (LC), Apical Sodium Dependent Bile Acids Transporter (ASBT), Nicotinamide Ribose (NR), Volixibat and Silybin
الوصف: Introduction Overweight and obesity in adults and children has escalatedat an astonishing rate in the past few decades bringing in a lot of the cost burden [1]. Increased Adipose Tissue (AT) as well as ectopic fat collection is typical properties of obesity which results in associated comorbidities like, Type 2 Diabetes Mellitus (T2DM), Hypertension, dyslipidemia.Recently Nonalcoholic Fatty Liver Diseases (NAFLD) has become the commonest chronic liver disease correlated with obesity [2]. Right now the therapy of obesity concentrates on lifestyle changes which include exercise.No reduction in obesity incidence has occurred in spite of lifestyle as well as diet changes over the past 3 decades [1]. We have reviewed multiple ways of treating obesity medically that includes Qsymia,Contrave, Thylakoids,GLP-1 agonists ,BAT thermogenesis enhancement utilizing mirabegron, probiotics etc but none have been of help in maintenance of weight reduction for long term other than Bariatric Surgery(BS) [3-9]. Further with escalating obesity liver disorders are increasing remarkably with no effective way of treating them .All over the world work is being done at war footing with the enhanced rates of liver transplants needed inthose under 50 yrs [10,11]. Thus we have further tried to present the advances done in working out some medical therapy to prevent propagation of NAFLD and halt it further to not progress till Nonalcoholic Steato Hepatitis (NASH) level,cirrhosis and Hepatocellular Carcinoma (HCC). Methods Thus we did an update on the further advances that are being made in treating NAFLD, NASH and carried out a PubMed search using the MeSH Terms NAFLD; NASH; HCC; Preventive or curative therapies. Results and Discussion We came across 377 articles out of which we chose 70 articles for updating the earlier information we had reviewed.No meta-analysis was done.
اللغة: English
URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______2659::c8dc78e083ff6d7bf077b9bf5f292685
https://zenodo.org/record/7931907
حقوق: OPEN
رقم الأكسشن: edsair.od......2659..c8dc78e083ff6d7bf077b9bf5f292685
قاعدة البيانات: OpenAIRE